Member Info for David1951c

Trek,
Thanks for comments. I looked at financials before investing and felt they had enough to get through with additional from Roche collaboration. Of course to accelerate may require more funds but unnecessarily low SP to get IIs on board will mean significant dilution and then those IIs sell out and hold down SP for a lengthy period as has been seen numerous cases. Timing is important and if ONC can wait for more good news to strengthen their hand and SP then it may not be so bad. More news is due and the important target now is to get the tests in use in NHS.
Agree with you comments on broker choice. If they had been appointed I would have sold all!

Unfortunately it also sometimes means a fund raise is coming - dilution and a lower SP. I built a sizeable (for me) holding - largest after Avacta and SNG. I may sell some to reduce risk of hit to SP.

If this leads to widespread use in NHS then it should be a test for use by health services in many markets worldwide. Looking forward to further announcements on contracts with the NHS. More to come in August and rest of the year from Roche collaboration and other developments.

Are there still 95.8m share warrants due to expire on 6 August? How many remain after that?

Uncertainty is a big issue and BMV need to act quickly so hopefully there will be more news well within 45 days which will also give a view on mining timelines. So far only £40k of sells but SP dropped 12% (!) so not too many are giving up and a few are buying. Risk increased but so has potential reward.

This could mean a big increase in value of BMV if the JV partner's share can be acquired at a sensible price. Confirmation of funding is helpful although the money has not been received yet. The big question for me is whether mining expected to begin in late 2020 will be delayed and if so by how long? RNS lacks detail on this point.

The recent news suggests the company is making significant headway with the latest study and with Roche. Further news on the Early CDT Lung test within Q1 2021 actually means by the end of August if I read the announcements correctly. With a relatively low Mcap of £88m there is a lot of potential still to come.

Although Reabold looks undervalued by Mcap based on WN, the SP was hit by the mixed results on Parta whereas UJO had better news on Biscathorpe. Although Reabold is now my largest O&G holding (after selling RRE) I decided that both have potential and hold both. Let's hope that both companies do well and news comes soon.

Thanks, Lunsam. I agree if you believe in a company, you stick with them. I do this on a number of other holdings. Mine was a gut reaction to the lenders and some terms are unclear. I sold some and will hold the rest pending further news.

I agree. I am positive on the business and outlook but negative on the deal and the lenders. I am not a large investor but cautious where these get involved. Sold some of mine after adding recently.

The work Iq-ai are doing looks very promising and worth investing in but having looked at the financials, they may need to raise funds in next 12 months. If Stone Checker is sold that might bring in cash as well as reduce losses. A small position taken and one to stay on the watchlist.

It is difficult to understand why approvals appear to take a long time when there is a desperate need for testing but that is how it is unfortunately - just look at other companies trying to move as quickly as possible with staff working long hours to make urgent progress. Patience is needed and there is a risk that other products will be approved and put into use before GDR. If you don't like risk then invest elsewhere.
I invested in Avacta and SNG 18 - 24 months ago and patience has been rewarded. SNG in particular do not release news very often but if you believe in the company and hold then you have a chance of making money. Having a risk appetite is important and sometimes sell if your confidence is low. SNG went below 10p but came good. Hopefully GDR will do the same. Hold tight if you believe but walk away or reduce if you are fearful.

Just catching up and read RNS. Great news. Any indication when results of trial for patients at home will be out?

In HL arrived on Wednesday. One issue is the amount shown as the cost was based on old SP and not 0.45p paid. This happened on AFC and Gore Street primarybid purchases too. As in Fund & Share account, I asked HL to amend the original cost to match amount paid under PB offer.

Hopefully RNS in next two weeks. Better to have a timeline BMV can meet as they seem confident of success. Perhaps there will be early news too on progress with grants and loans which will reduce funds required to produce. The initial amount is not that large anyway and is one of the factors making this a good investment potentially. SP dropped slightly. Tempted to add but 1m is enough in one investment for me.

Made a small 10k investment today (shown as a sell) @45.36. Still researching prior to increasing. Potential significant in USA and UK and possibly into Germany. Wanted to evaluate competition. Has anyone looked at that?

I am not a regular poster but read and appreciate the very knowledgeable people's postings.
I was tempted to add at lower SP but I am cautious because the lack of news after the announcement three months ago. "On completion of the Arrangement, which is subject to Zambian Ministry (ZM) approval, the Company will be in a position to finalise third-party offtake agreements for Star Zinc and to continue its exploration activities on the Ka****u prospect. "
Whilst getting ZM approval looks straightforward, this seems like an unhelpful delay at best. CB purchased 2.6m additional shares in June so I was expecting more progress by now. Am I impatient?

UPL is "pleased to announce" that existing shareholders have once again been badly hit. Why they can be pleased at continuous failure is amazing! Thankfully I only have a small shareholding.

RNS does not give any idea if this will impact NF project or the other USA pipeline projects. PIs are understandably cautious and risk averse. Many are taking advantage of lower SP as I have but the lack of information makes risk assessment high impossible as well as possible legal costs.

There are also possible subsidies as mentioned in RNS "Although they will be not be included in cash flow projections, there are number of subsidies available to the Company which will have a significant impact on capital costs. These include on-mine exploration drilling programs, subsidised capital development for main access ways, productivity initiatives involving facilities and equipment and vertical shaft construction for ventilation. There are a range of subsidies related to mine support, water discharge, monitoring and safety equipment. In addition to all the subsidies which range from 40-60 percent of direct costs, there is substantial assistance offered for environmental initiatives. Whilst the Company intends to apply for various subsidies that are available and is optimistic for a positive outcome there can be no guarantee that these will be granted."
One other plus for me is the SP stability and this has not moved much in recent weeks.